ARTA
CALA

A.R.T. Advisors’s Calithera Biosciences, Inc CALA Stock Holding History

A.R.T. Advisors’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,777
Closed -$203K – 1174
2019
Q4 		$203K Buy
1,777
+1,100
+162% +$82.7K 0.01% 1154
2019
Q3 		$42K Buy
+677
New +$54.2K ﹤0.01% 1330
2018
Q1 		– Sell
-1,403
Closed -$234K – 1839
2017
Q4 		$234K Buy
+1,403
New +$359K 0.01% 1115
2016
Q3 		– Sell
-723
Closed -$53K – 1305
2016
Q2 		$53K Buy
+723
New +$72.4K ﹤0.01% 1263
2015
Q1 		– Sell
-861
Closed -$347K – 1779
2014
Q4 		$347K Buy
+861
New +$225K 0.01% 1048

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

A.R.T. Advisors's CALA Position: Q1 2020 in Review

A.R.T. Advisors sold out of Calithera Biosciences, Inc (CALA) in Q1 2020, closing a stake of 1,777 shares — an estimated $203K sold.

A.R.T. Advisors first reported a position in CALA in Q4 2014 and held it in 5 quarters. The position peaked at $347K in Q4 2014. 80 funds tracked by Wall St. Rank hold CALA as of Q1 2020.

  • A.R.T. Advisors reported no remaining Calithera Biosciences, Inc position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 1,777 Calithera Biosciences, Inc shares in Q1 2020, an estimated $203K.
  • A.R.T. Advisors first reported a position in Calithera Biosciences, Inc in Q4 2014 and held it in 5 quarters.
  • A.R.T. Advisors's Calithera Biosciences, Inc position peaked at $347K in Q4 2014.
  • 80 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.